04/16/2015 - 9:00am

According to the Food and Drug Administration, heart failure is a common condition that affects close to 5.1 million people in the United States. The condition arises when the heart cannot pump enough blood to meet the body’s needs. 

04/14/2015 - 1:45pm

Actavis and Medicines360, a nonprofit women’s health pharmaceutical company, on Monday announced that Liletta (levonorgestrel-releasing intrauterine system) in 52 mg is now available in the United States.

04/07/2015 - 11:05am

Mylan on Tuesday announced the launch of norethindrone and ethinyl estradiol tablets (chewable) 0.8 mg/0.025 mg and ferrous fumarate tablets, 75 mg (chewable).

04/01/2015 - 12:13pm

Teva said it expects the product to be available to patients during second-quarter 2015.

03/31/2015 - 12:11pm

The drug is Food and Drug Administration-approved to treat opioid-induced constipation in adults with chronic, non-cancer pain. 

03/31/2015 - 9:29am

Teva Pharmaceutical Industries announced the launch of generic Exforge (amlodipine and valsartan) tablets, which are indicated for the treatment of hypertension. 

 

03/13/2015 - 10:08am

Actavis on Friday announced that the Food and Drug Administration approved Saphris for the treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients.

03/11/2015 - 12:50pm

Mylan expanded its portfolio of generic products with the U.S. launch of buprenorphine hydrochloride sublingual tablets in 2-mg and 8-mg strengths, the generic version of Subutex from Reckitt Benckiser.

03/11/2015 - 12:40pm

Mylan on Wednesday announced the launch of disulfiram tablets USP in dosage strengths of 250 mg and 500 mg.